Concepedia

H. L. Park

HL

Statistics

Publications

2

Citations

108

H-Index

2

Active since

2014

Affiliations

Catholic University of Korea(Current)

Il-Yang Pharmaceutical (South Korea)

H. L. Park is an author at Catholic University of Korea specializing in medicine, pharmacology, and tyrosine kinase inhibitors.

Publications per year

2014–2014

2

Publications

2

Efficacy and safety of radotinib in chronic phase chronic myeloid leukemia patients with resistance or intolerance to BCR-ABL1 tyrosine kinase inhibitors

S.-H. Kim, Hari Menon, Saengsuree Jootar et al. · Haematologica · 2014 · 70 citations · Full text

, , +13

The pharmacokinetics, pharmacodynamics and safety of oral doses of ilaprazole 10, 20 and 40 mg and esomeprazole 40 mg in healthy subjects: a randomised, open‐label crossover study

Jung-Wook Shin, J. Y. Lee, K. H. Cho et al. · Alimentary Pharmacology & Therapeutics · 2014 · 38 citations

, , +11

1–2 of 2